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Background: Heart failure (HF) is a leading cause of adult hospitalization, morbidity, and mortality. We evaluated the influence of myocardial 
ischemia and left ventricular ejection fraction (LVEF) on outcomes in patients who were hospitalized with new onset HF.
Methods: We prospectively recruited 201 consecutive patients hospitalized for a first episode of HF from 17 medical centers across Europe and 
North America. All patients received gated single-photon emission computed tomographic testing with standardized study interpretations by trained 
core laboratory investigators. Predefined data from routine care were collected and aggregated. Computerized scoring was performed at the core 
laboratory and participants with a summed difference score ≥4 were defined as having myocardial ischemia. Participants were categorized as having 
systolic heart failure (SHF) (LVEF<40%) or nonsystolic heart failure (NS-HF) (LVEF≥40%). A proportional hazards model was used to assess the 
impact of clinical predictors on the outcomes of mortality, cardiac rehospitalization and a combined outcome within 2 years of study enrollment.
Results: : 180 patients fulfilled study criteria, completed the follow-up and were included in analysis. The mean age was 65.5 ± 14.6 years and 
57.2% (n = 103) were male. Myocardial ischemia was present in 45 (41.2%) patients with SHF and 19 (27.5%) patients with NS-HF (p <0.01). 
During the follow-up period, 11.1% (n=20) died and 42.2% (n=76) experienced a recurrent cardiovascular hospitalization. Patients with NS-HF and 
evidence of ischemia had the highest (73.7%) composite event rate compared with the other cohorts (multivariate OR=3.29, 95% CI 1.69-6.42, 
p=0.001).
Conclusions: Of patients with new-onset HF, those with NS-HF and myocardial ischemia are at the highest risk for morbidity and mortality after the 
initial hospitalization.
